The Global Specimen validity test reagents market is projected to grow at a CAGR of 7 %. The emerging technology & innovation in healthcare has developed the specimen validity test through urine samples. Specimen validity testing (SVT) is performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. It provides clinicians with critical information about the accuracy and reliability of drug test results. Drug testing is a well-established & readily available clinical tool to objectively assess an individual’s illicit drug use behaviours. Illicit drug use is defined as the use of marijuana, cocaine, heroin, hallucinogens, inhalants, or the non-medical use of prescription. According Substance Abuse and Mental Health Services Administration (SAMHSA) nearly 8.7% of the American population aged 12 or older participate in illicit drug use. The market is driven by testing of illicit drug use by many people in various regions. Increase in number of drug abuse population and stringent regulatory guidelines enforced by regulatory agencies in developed countries such as United States are prime factors that are driving the growth of SVT reagent market. North America alone contributed more than 60 percent of total market share in 2020.
Illicit drug consist of Marijuana, opioids, cocaine & other drugs. The World Health Organization (WHO) reports that cannabis is the most widely used illicit drug in the world, representing half of all drug seizures worldwide. An estimate of 147 million people as 2.5% of the world's population uses marijuana each year. The United States: 5.89%, Greenland: 5.63%, Mongolia: 5.24%, United Kingdom: 5.22%&New Zealand: 4.91% are the top 5 countries with major drug illicit. These countries also have substantial growth in health care to test the people with major use of drugs. The specimen validity test is performed on large scale in these countries. As a result, many people end with the rehabilitation centres, strict laws are made to control the drug market. The specimen validity test market tends to grow as significant use of illicit drugs is accounted for. The market is expected to grow in future.
In spite of stringent drug policies and punitive laws, the United States has high levels of lifetime illegal drug use. A 2018 study found that the United States has illicit drug use rates among the highest in the world. Eastern European nations reported the highest rates of alcohol consumption. The 2019 NSDUH indicated that more than 12 million young adults (ages 18 to 25) used marijuana. Findings from the 2019 NSDUH indicated that 3.5% of the U.S. population aged 12 & over misused prescription pain relievers. In the 2019 NSDUH, there were an estimated 97,000 people aged 12 & over in the U.S. who had used cocaine use in the past year. As a significant rise in the market, the market grew substantially as testing increased along with the drug use. The Asia Pacific was the region with emerging growth followed by North America & Europe.
The ongoing stress and uncertainty of COVID-19 have led to increased demand for mental health services from psychologists in the U.S. however conditions such as anxiety & depression aren’t the only mental health issues people are facing. Experts say misuse of opioids and stimulants is also on the rise & psychologists are in a good position to help. In 2020, according to the American Medical Association report, in December more than 40 U.S. states have seen increases in opioid-related mortality along with ongoing concerns for those with substance use disorders. The pandemic accounted for major testing in many regions as drug use increased.
Key players in the market are Alere, Thermo Fisher, Scitek, LabCorp, Quest Diagnostics, Alfa Scientific Designs, American Bio Medica Corporation, Express Diagnostics, ACM Global Laboratories, Clinical Reference Laboratory & Premier Biotech. The key strategy used by these companies is focusing on delivering innovative, customized drug testing products and solutions backed by an unwavering commitment to the consumers.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Specimen Validity Test Reagents market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
Test
| |
Application Areas
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
